Sanofi (NASDAQ:SNY) Shares Bought by BKM Wealth Management LLC

BKM Wealth Management LLC grew its holdings in shares of Sanofi (NASDAQ:SNY) by 74.3% during the 1st quarter, HoldingsChannel reports. The firm owned 8,314 shares of the company’s stock after buying an additional 3,543 shares during the period. BKM Wealth Management LLC’s holdings in Sanofi were worth $404,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Rise Advisors LLC boosted its stake in Sanofi by 98.4% during the 4th quarter. Rise Advisors LLC now owns 506 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the last quarter. Salem Investment Counselors Inc. acquired a new stake in Sanofi during the 4th quarter worth $27,000. Venturi Wealth Management LLC boosted its stake in Sanofi by 163.5% during the 4th quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock worth $27,000 after purchasing an additional 332 shares during the last quarter. Frazier Financial Advisors LLC acquired a new stake in Sanofi during the 4th quarter worth $28,000. Finally, Register Financial Advisors LLC acquired a new stake in Sanofi during the 1st quarter worth $29,000. Institutional investors and hedge funds own 10.04% of the company’s stock.

Sanofi Trading Up 2.2 %

Shares of SNY opened at $49.59 on Tuesday. The firm’s fifty day moving average is $48.68 and its two-hundred day moving average is $48.57. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The stock has a market cap of $125.60 billion, a PE ratio of 24.92, a price-to-earnings-growth ratio of 1.50 and a beta of 0.59. Sanofi has a 52-week low of $42.63 and a 52-week high of $55.72.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings results on Thursday, April 25th. The company reported $0.96 earnings per share for the quarter, meeting the consensus estimate of $0.96. The firm had revenue of $11.36 billion for the quarter, compared to analysts’ expectations of $11.75 billion. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. Research analysts forecast that Sanofi will post 4.13 earnings per share for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.